查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942732

2026年全球數位療法市場報告

Digital Therapeutics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，數位療法市場呈指數級成長，預計將從2025年的109.3億美元成長到2026年的140.2億美元，複合年成長率達28.3%。這一成長歸因於智慧型手機在醫療保健領域的滲透率不斷提高、數位健康解決方案的接受度不斷提高、遠端醫療服務的擴展、數位療法監管核准速度加快以及慢性病負擔日益加重。

預計未來幾年，數位療法市場將呈指數級成長，到2030年市場規模將達到378.2億美元，複合年成長率（CAGR）為28.1%。預測期內的成長要素包括：數位療法報銷支持力度的加大、對個人化數位醫療需求的不斷成長、人工智慧驅動的治療平台的擴展、醫療服務提供者與科技公司之間合作的加強，以及對預防性數位健康的日益重視。預測期內的關鍵趨勢包括：基於軟體的治療解決方案的日益普及、穿戴式健康設備的日益整合、遠端患者監護平台的廣泛應用、循證數位醫療項目的擴展，以及對個性化治療路徑的日益關注。

慢性病發病率的不斷上升預計將成為推動數位療法市場擴張的主要因素。需要長期醫療照護的慢性病對患者的日常生活影響巨大。數位療法作為一種以軟體為基礎的介入手段，提供實證治療方案，能夠增強慢性病管理，為患者提供更多治療選擇。值得注意的是，根據美國疾病管制與預防中心（CDC）截至2022年7月的數據，十分之六的美國成年人患有慢性病，十分之四的成年人患有兩種或兩種以上的慢性病，​​例如心臟病、糖尿病和慢性肺病。慢性病的高發生率顯著推動了數位療法市場的成長。

數位療法市場的主要企業正致力於技術創新，例如處方箋數位行為療法平台，以擴大治療覆蓋範圍、增強病人參與並提供經臨床檢驗的療效。處方箋數位行為療法平台是基於軟體的干涉措施，可透過智慧型手機或平板電腦提供。它們融合了循證要素，例如認知行為療法 (CBT)、遠端監測和互動式目標追蹤，從而實現擴充性的無藥物疾病管理和個性化患者支持。例如，2023 年 7 月，總部位於美國的處方箋數位療法公司 Better Therapeutics 推出了 AspyreRx（原名 BT 001），這是一款專為 2 型糖尿病設計的數位療法。該解決方案透過智慧型手機應用程式提供為期 90 天的自我管理計劃，包括每週一次的 CBT 課程、個人化目標設定以及血糖值和生活方式指標的監測。臨床研究已證實，該方案能夠持續降低糖化血紅蛋白 (HbA1c) 水平、改善體重並提高生活品質。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球數位療法市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫學
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 以軟體為基礎的治療解決方案正日益普及
    • 穿戴式健康設備的日益普及
    • 遠端患者監護平台的使用範圍不斷擴大
    • 擴大循證數位醫療項目
    • 越來越重視個人化治療方案

第5章 終端用戶產業市場分析

  • 醫院
  • 醫療保健提供者
  • 數位健康公司
  • 病人
  • 保險公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球數位療法市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球數位療法市場規模、對比及成長率分析
  • 全球數位療法市場表現：規模與成長，2020-2025年
  • 全球數位療法市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 軟體、裝置
  • 按銷售管道
  • 企業對企業 (B2B)、企業對消費者 (B2C)
  • 透過使用
  • 預防、治療或護理相關的應用
  • 按類型細分：軟體
  • 行動應用程式、基於網路的平台和數位治療軟體
  • 按類型細分：設備
  • 穿戴式裝置、生物感測器、數位治療設備

第10章 區域與國家分析

  • 全球數位療法市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球數位療法市場：國家/地區、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 數位療法市場：競爭格局及市場佔有率（2024年）
  • 數位療法市場：公司估值矩陣
  • 數位療法市場：公司概況
    • Omada Health Inc.
    • WellDoc Inc.
    • 2Morrow Inc.
    • Propeller Health
    • Pear Therapeutics

第37章：其他領先和創新企業

  • Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年數位療法市場：提供新機會的國家
  • 2030年數位療法市場：充滿新機會的細分領域
  • 2030年數位療法市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MDTHE01_G26Q1

Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.

The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.

Tariffs are influencing the digital therapeutics market by increasing costs of imported wearable components, biosensors, electronic modules, and supporting hardware devices. Healthcare providers and technology firms in North America and Europe are most affected due to dependence on imported electronics, while Asia-Pacific faces cost pressure on device manufacturing. These tariffs are increasing development and deployment costs. However, they are also encouraging local device assembly, regional software innovation, and greater emphasis on scalable software-centric therapeutic solutions.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $10.93 billion in 2025 to $14.02 billion in 2026 at a compound annual growth rate (CAGR) of 28.3%. The growth in the historic period can be attributed to growing smartphone penetration in healthcare, increased acceptance of digital health solutions, expansion of telemedicine services, early regulatory approvals for digital therapeutics, rising chronic disease burden.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $37.82 billion in 2030 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to increasing reimbursement support for digital therapeutics, rising demand for personalized digital care, expansion of ai-driven treatment platforms, growing partnerships between healthcare providers and tech firms, increasing focus on preventive digital health. Major trends in the forecast period include increasing adoption of software-based therapeutic solutions, rising integration of wearable health devices, growing use of remote patient monitoring platforms, expansion of evidence-based digital care programs, enhanced focus on personalized treatment pathways.

The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.

Major companies operating in the digital therapeutics market are concentrating on technological advancements such as prescription-only digital behavioral therapy platforms to expand treatment access, strengthen patient engagement, and deliver clinically validated outcomes. A prescription-only digital behavioral therapy platform employs software-based interventions delivered through smartphones or tablets, incorporating evidence-based components such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking, enabling scalable, drug-free disease management and personalized patient support. For example, in July 2023, Better Therapeutics, a U.S.-based prescription digital therapeutics company, introduced AspyreRx (formerly BT 001), a digital therapeutic designed for type 2 diabetes. The solution offers a 90-day self-guided program via a smartphone application, including weekly CBT sessions, individualized goal setting, and monitoring of blood glucose and lifestyle metrics, with clinical studies showing sustained reductions in HbA1c, weight improvements, and enhanced quality-of-life outcomes.

In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.

Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Software; Devices
  • 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
  • 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
  • Subsegments:
  • 1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software
  • 2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
  • Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Xealth; CogniFit Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Digital Therapeutics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Digital Therapeutics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Digital Therapeutics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Digital Therapeutics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Software-Based Therapeutic Solutions
    • 4.2.2 Rising Integration Of Wearable Health Devices
    • 4.2.3 Growing Use Of Remote Patient Monitoring Platforms
    • 4.2.4 Expansion Of Evidence-Based Digital Care Programs
    • 4.2.5 Enhanced Focus On Personalized Treatment Pathways

5. Digital Therapeutics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Healthcare Providers
  • 5.3 Digital Health Companies
  • 5.4 Patients
  • 5.5 Insurance Providers

6. Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Digital Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Digital Therapeutics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Digital Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Digital Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Digital Therapeutics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Digital Therapeutics Market Segmentation

  • 9.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Devices
  • 9.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Business-To-Business (B2B), Business-To-Consumers (B2C)
  • 9.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Preventive Applications, Treatment Or Care-Related Applications
  • 9.4. Global Digital Therapeutics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mobile Applications, Web-Based Platforms, Digital Therapeutics Software
  • 9.5. Global Digital Therapeutics Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Wearable Devices, Biosensors, Digital Therapeutic Devices

10. Digital Therapeutics Market Regional And Country Analysis

  • 10.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Digital Therapeutics Market

  • 11.1. Asia-Pacific Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Digital Therapeutics Market

  • 12.1. China Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Digital Therapeutics Market

  • 13.1. India Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Digital Therapeutics Market

  • 14.1. Japan Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Digital Therapeutics Market

  • 15.1. Australia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Digital Therapeutics Market

  • 16.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Digital Therapeutics Market

  • 17.1. South Korea Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Digital Therapeutics Market

  • 18.1. Taiwan Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Digital Therapeutics Market

  • 19.1. South East Asia Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Digital Therapeutics Market

  • 20.1. Western Europe Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Digital Therapeutics Market

  • 21.1. UK Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Digital Therapeutics Market

  • 22.1. Germany Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Digital Therapeutics Market

  • 23.1. France Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Digital Therapeutics Market

  • 24.1. Italy Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Digital Therapeutics Market

  • 25.1. Spain Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Digital Therapeutics Market

  • 26.1. Eastern Europe Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Digital Therapeutics Market

  • 27.1. Russia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Digital Therapeutics Market

  • 28.1. North America Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Digital Therapeutics Market

  • 29.1. USA Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Digital Therapeutics Market

  • 30.1. Canada Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Digital Therapeutics Market

  • 31.1. South America Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Digital Therapeutics Market

  • 32.1. Brazil Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Digital Therapeutics Market

  • 33.1. Middle East Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Digital Therapeutics Market

  • 34.1. Africa Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Digital Therapeutics Market Regulatory and Investment Landscape

36. Digital Therapeutics Market Competitive Landscape And Company Profiles

  • 36.1. Digital Therapeutics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Digital Therapeutics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Digital Therapeutics Market Company Profiles
    • 36.3.1. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Propeller Health Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. Digital Therapeutics Market Other Major And Innovative Companies

  • Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health

38. Global Digital Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Digital Therapeutics Market

40. Digital Therapeutics Market High Potential Countries, Segments and Strategies

  • 40.1 Digital Therapeutics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Digital Therapeutics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Digital Therapeutics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer